SKI-178

SKI-178 is an inhibitor of SK1 and SK2 used in studies of Metabolic Signaling. In practice, this places the compound in experiments that measure metabolic regulation, energy sensing, and enzyme-linked homeostasis in cancer, cell signaling, and immunology models.

By inhibiting SK1 and SK2, SKI-178 can be used to examine metabolic regulation, energy sensing, and enzyme-linked homeostasis. The kinase annotation adds relevance to biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping in the same experimental setting. In cancer, cell signaling, and immunology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving SK1 and SK2
• Pathway perturbation studies connected to Metabolic Signaling
• Concentration-response inhibition and target-dependence studies
• Biochemical kinase assays, phospho-signaling studies, and selectivity profiling

Overall, SKI-178 is appropriate when a defined chemical perturbant is needed to connect SK1 and SK2 with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cell signaling, and immunology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.